v3.25.2
Income (Loss) Per Share (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Earnings Per Share [Abstract]    
Schedule of Computation of Basic and Diluted Earnings Per Share

The following table shows the computation of basic and diluted earnings per share for the three months ended March 31, 2025 and 2024 in thousands, except share and per share amounts:

 

 

 

Three Months Ended March 31,

 

 

2025

 

 

2024

 

Numerator:

 

 

 

 

 

 

Net Income (Loss)

 

$

154

 

 

$

(6,379

)

Denominator:

 

 

 

 

 

 

Weighted average common shares outstanding - Basic

 

 

62,205,192

 

 

 

59,234,601

 

Dilutive effect of stock options, RSUs and warrants

 

 

 

 

 

 

Weighted average common shares outstanding - Diluted

 

 

69,619,293

 

 

 

59,234,601

 

Basic loss per share

 

$

-

 

 

$

(0.11

)

Diluted loss per share (1)

 

$

-

 

 

$

(0.11

)

 

(1) There were 17,732,764 warrants, 196,667 options, and 7,294,595 RSUs outstanding at March 31, 2025 and there were 17,680,187 warrants, 313,334 options, and 5,965,022 RSUs outstanding at March 31, 2024. The Company excluded the warrants for the period ended March 31, 2025, and excluded the warrants, options and RSUs from the calculation of diluted EPS for the period ended March 31, 2024 as inclusion would have an anti-dilutive effect.

The following table shows the computation of basic and diluted earnings per share in thousands, except share and per share amounts:

 

 

 

Year Ended December 31,

 

 

2024

 

 

2023

 

Numerator:

 

 

 

 

 

 

Net loss

 

$

(11,472

)

 

$

(21,011

)

Denominator:

 

 

 

 

 

 

Weighted average common shares outstanding - Basic

 

 

60,359,587

 

 

 

56,763,879

 

Dilutive effect of stock options, RSUs and warrants

 

 

 

 

 

 

Weighted average common shares outstanding - Diluted

 

 

60,359,587

 

 

 

56,763,879

 

Basic loss per share

 

$

(0.19

)

 

$

(0.37

)

Diluted loss per share (1)

 

$

(0.19

)

 

$

(0.37

)

 

(1) There were 17,732,764 warrants, 246,667 options, and 5,373,373 RSUs outstanding at December 31, 2024 and there were 22,518,894 warrants, 470,668 options, and 5,056,270 RSUs outstanding at December 31, 2023. The Company excluded the warrants, options and RSUs from the calculation of diluted EPS for the years ended December 31, 2024 and 2023 as inclusion would have an anti-dilutive effect.